[Markers of thrombophilia in patients with retinal vein thrombosis]

Rev Med Chil. 2005 Feb;133(2):167-74. doi: 10.4067/s0034-98872005000200003. Epub 2005 Apr 7.
[Article in Spanish]

Abstract

Background: Thrombophilia is an alteration of hemostasis that increases the risk to venous or arterial thrombosis. This condition may be the underlying cause of retinal vein thrombosis.

Aim: To study the presence of thrombophilia in patients with retinal vein thrombosis.

Patients and methods: Prospective study of 55 patients aged 22 to 86 years, with retinal vein thrombosis (central or branch). Antithrombin III, coagulant protein C, functional protein S, resistance to activated C protein, homocysteine, prothrombin G20210A gene, lupus anticoagulant and anticardiolipin antibodies were measured in all.

Results: Seventeen patients had thrombophilic markers (antiphospholipid syndrome in seven, hyperhomocysteinemia in six and resistance to protein C in three). Of these 17 patients, 53% had high blood pressure, 35% an abnormal serum lipid profile and 23% a personal history of thrombosis. The thrombosis was central in 12 (ischemic in four) and of a branch in five (ischemic in two).

Conclusions: Thrombophilic markers must be assessed in patients with retinal vein thrombosis.

Publication types

  • English Abstract
  • Multicenter Study

MeSH terms

  • Activated Protein C Resistance / complications
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Coagulation Tests
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Protein S Deficiency / blood
  • Retinal Vein Occlusion / blood
  • Retinal Vein Occlusion / etiology*
  • Risk Factors
  • Sex Distribution
  • Thrombophilia / blood
  • Thrombophilia / complications*

Substances

  • Biomarkers